Literature DB >> 19016807

Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs.

L Kolte1, J C Gaardbo, K Skogstrand, L P Ryder, A K Ersbøll, S D Nielsen.   

Abstract

This study determines levels of regulatory T cells (T(regs)), naive T(regs), immune activation and cytokine patterns in 15 adult human immunodeficiency virus (HIV)-infected patients receiving prolonged highly active anti-retroviral therapy (HAART) who have known thymic output, and explores if naive T(regs) may represent recent thymic emigrant T(regs). HIV-infected patients treated with HAART with a median of 1 and 5 years were compared with healthy controls. Percentages of T(regs) (CD3(+)CD4(+)CD25(+)CD127(low)), naive T(regs) (CD3(+)CD4(+)CD25(+)CD45RA(+)) and activation markers (CD38(+)human leucocyte antigen D-related) were determined by flow cytometry. Forkhead box P3 mRNA expression and T cell receptor excision circles (T(REC)) content in CD4(+) cells were determined by polymerase chain reaction and cytokines analysed with Luminex technology. Levels of T(regs) were significantly higher in HIV-infected patients compared with controls, both after 1 and 5 years of HAART (P<0.001), despite fully suppressed HIV-RNA and normalization of both CD4 counts, immune activation and cytokine patterns. Furthermore, levels of naive T(regs) were elevated significantly in HIV-infected patients (P<0.001) and were associated with thymic output measured as the T(REC) frequency in CD4(+) cells (P=0.038). In summary, T(reg) levels in HIV-infected patients are elevated even after 5 years of HAART. Increased thymic production of naive T(regs) may contribute to higher T(reg) levels in HIV-infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016807      PMCID: PMC2665678          DOI: 10.1111/j.1365-2249.2008.03803.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  Statistical methods for efficiency adjusted real-time PCR quantification.

Authors:  Joshua S Yuan; Donglin Wang; C Neal Stewart
Journal:  Biotechnol J       Date:  2008-01       Impact factor: 4.677

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 3.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

4.  Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.

Authors:  J C Gaardbo; S D Nielsen; S J Vedel; A K Ersbøll; L Harritshøj; L P Ryder; J O Nielsen; L Kolte
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

5.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Authors:  Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

6.  Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection.

Authors:  Amanda K Antons; Rui Wang; Kyra Oswald-Richter; Michelle Tseng; Christopher W Arendt; Spyros A Kalams; Derya Unutmaz
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 7.  Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus.

Authors:  Ana Claudia Zenclussen; Anne Schumacher; Maria Laura Zenclussen; Paul Wafula; Hans-Dieter Volk
Journal:  Expert Rev Mol Med       Date:  2007-04-27       Impact factor: 5.600

8.  Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis.

Authors:  Jürgen Haas; Benedikt Fritzsching; Petra Trübswetter; Mirjam Korporal; Linda Milkova; Brigitte Fritz; Diana Vobis; Peter H Krammer; Elisabeth Suri-Payer; Brigitte Wildemann
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

Review 9.  Foxp3 in control of the regulatory T cell lineage.

Authors:  Ye Zheng; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2007-05       Impact factor: 25.606

10.  Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.

Authors:  Andrew Lim; Dino Tan; Patricia Price; Adeeba Kamarulzaman; Hong-Yien Tan; Ian James; Martyn A French
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

View more
  23 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.

Authors:  Malika Hale; Taylor Mesojednik; Guillermo S Romano Ibarra; Jaya Sahni; Alison Bernard; Karen Sommer; Andrew M Scharenberg; David J Rawlings; Thor A Wagner
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

3.  Combining Cell and Gene Therapy in an Effort to Eradicate HIV.

Authors:  Thor A Wagner
Journal:  AIDS Patient Care STDS       Date:  2016-12       Impact factor: 5.078

Review 4.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

Review 5.  Quarter Century of Anti-HIV CAR T Cells.

Authors:  Thor A Wagner
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

6.  Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques.

Authors:  Jeffy George; Egidio Brocca Cofano; Elizabeth Lybarger; Mark Louder; Bernard A P Lafont; John R Mascola; Marjorie Robert-Guroff; Joseph J Mattapallil
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-17       Impact factor: 2.205

7.  HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.

Authors:  Rachel E Owen; John W Heitman; Dale F Hirschkorn; Marion C Lanteri; Hope H Biswas; Jeffrey N Martin; Melissa R Krone; Steven G Deeks; Philip J Norris
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

8.  FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.

Authors:  Melinda S Suchard; Elizabeth Mayne; Victoria A Green; Sharon Shalekoff; Samantha L Donninger; Wendy S Stevens; Clive M Gray; Caroline T Tiemessen
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

Review 9.  T-cell therapies for HIV.

Authors:  Sharon Lam; Catherine Bollard
Journal:  Immunotherapy       Date:  2013-04       Impact factor: 4.196

Review 10.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.